Difference between revisions of "Team:Tongji China/Judging form"

Revision as of 14:58, 12 October 2018

For Judges

Bronze medal

Registration and Jamboree Attendance

We've successfully registered and will attend the Giant Jamboree.

Attributions

We have clear attributions.
https://2018.igem.org/Team:Tongji_China/Attributions

Characterization

We've successfully participated in the 2018 InterLab Study.
https://2018.igem.org/Team:Tongji_China/InterLab

Silver medal

Validated Part

We've made several new biobricks relating to T3SS and cancer immunotherapy and successfully submitted them. The number of them are

Collaboration

We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.
https://2018.igem.org/Team:Tongji_China/Collaborations

Human Practices

We’ve done education work in high school and some surveys according to our projects.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Gold medal

Integrated Human Practices

We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Model Your Project

We've made a model of the antigen and SNVs.
https://2018.igem.org/Team:Tongji_China/Model

Demonstration of Your Work

We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.
https://2018.igem.org/Team:Tongji_China/Demonstrate

@@ Line 67: / Line 67: @@
 		</div>
 		<div class="content">
-			We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product.
+			We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
 			<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br>
@@ Line 75: / Line 75: @@
 		</div>
 		<div class="content">
-			We’ve made the model of the antigen and SNVs.<br>
+			We've made a model of the antigen and SNVs.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a><br><br>
 		</div>
@@ Line 82: / Line 82: @@
 		</div>
 		<div class="content">
-			We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.<br>
+			We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.<br>
 			<a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a><br><br>
 		</div>